Dario A. Paggiarino - Net Worth and Insider Trading

Dario A. Paggiarino Net Worth

The estimated net worth of Dario A. Paggiarino is at least $262,836 dollars as of 2024-12-28. Dario A. Paggiarino is the Chief Medical Officer of EyePoint Pharmaceuticals Inc and owns about 36,505 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $262,836. Details can be seen in Dario A. Paggiarino's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dario A. Paggiarino has not made any transactions after 2024-01-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Dario A. Paggiarino

To

Dario A. Paggiarino Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dario A. Paggiarino owns 2 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , and Apollo Endosurgery Inc (APEN) .

Click here to see the complete history of Dario A. Paggiarino’s form 4 insider trades.

Insider Ownership Summary of Dario A. Paggiarino

Ticker Comapny Transaction Date Type of Owner
EYPT EyePoint Pharmaceuticals Inc 2024-01-26 Chief Medical Officer
APEN Apollo Endosurgery Inc 2013-04-15 Sr VP & Chief Dev Officer

Dario A. Paggiarino Latest Holdings Summary

Dario A. Paggiarino currently owns a total of 1 stock. Dario A. Paggiarino owns 36,505 shares of EyePoint Pharmaceuticals Inc (EYPT) as of January 26, 2024, with a value of $262,836.

Latest Holdings of Dario A. Paggiarino

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EYPT EyePoint Pharmaceuticals Inc 2024-01-26 36,505 7.20 262,836

Holding Weightings of Dario A. Paggiarino


Dario A. Paggiarino Form 4 Trading Tracker

According to the SEC Form 4 filings, Dario A. Paggiarino has made a total of 6 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the sale of 49,325 shares on January 26, 2024, which brought Dario A. Paggiarino around $1 Million.

Insider Trading History of Dario A. Paggiarino

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dario A. Paggiarino Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dario A. Paggiarino Ownership Network

Ownership Network List of Dario A. Paggiarino

No Data

Ownership Network Relation of Dario A. Paggiarino

Insider Network Chart

Dario A. Paggiarino Owned Company Details

What does EyePoint Pharmaceuticals Inc do?

Who are the key executives at EyePoint Pharmaceuticals Inc?

Dario A. Paggiarino is the Chief Medical Officer of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Corp Dev.&Strat. Officer Michael Craig Pine .

EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary

Over the past 18 months, Dario A. Paggiarino made 6 insider transaction in EyePoint Pharmaceuticals Inc (EYPT) with a net sale of 121,307. Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp , and a net sale of 73,192 shares made by David Scott Jones .

In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,229,810 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,487 shares.

EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

EyePoint Pharmaceuticals Inc Insider Transactions

No Available Data

Dario A. Paggiarino Mailing Address

Above is the net worth, insider trading, and ownership report for Dario A. Paggiarino. You might contact Dario A. Paggiarino via mailing address: 4025 Sorrento Valley Blvd., San Diego Ca 92121.

Discussions on Dario A. Paggiarino

No discussions yet.